FDA Announces Class I Recall On Arrow International Cardiac Catheter Device
The US FDA has announced a high-risk class I recall on a cardiac catheter from Teleflex Inc. subsidiary Arrow International due to the risk of tip damage during use.
You may also be interested in...
The US Food and Drug Administration and the Veterans Health Administration are partnering to create tools that can help novel technology reach patients more quickly and easily.
The US FDA has approved additional indications for Thermo Fisher Scientific’s Oncomine Dx Target, allowing the companion diagnostic to be used to detect more varieties of lung and thyroid cancer.
Committee leaders in the US Congress have agreed on a stripped-down path to user fee reauthorization, which will not include FDA oversight of diagnostic tests.